Jefferies Group LLC Alnylam Pharmaceuticals, Inc. Transaction History

Jefferies Group LLC

$10.2 Billion
Q3 2022

A detailed history of Jefferies Group LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Jefferies Group LLC holds 46,726 shares of ALNY stock, worth $11 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

46,726

Previous 16,895 176.57%

Holding current value

$11 Million

Previous $2.46 Million 279.55%

% of portfolio

0.09%

Previous 0.02%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Sep 21, 2023	BUY	$138.54 - $232.0 $4.13 Million - $6.92 Million	29,831 Added 176.57%	46,726 $9.35 Million
Q3 2022 Nov 14, 2022	BUY	$138.54 - $232.0 $4.13 Million - $6.92 Million	29,831 Added 176.57%	46,726 $9.35 Million
Q2 2022 Sep 21, 2023	SELL	$120.42 - $169.29 $348,375 - $489,755	-2,893 Reduced 14.62%	16,895 $2.46 Million
Q2 2022 Aug 15, 2022	SELL	$120.42 - $169.29 $348,375 - $489,755	-2,893 Reduced 14.62%	16,895 $2.46 Million
Q1 2022 Sep 21, 2023	SELL	$127.18 - $173.91 $1.55 Million - $2.12 Million	-12,171 Reduced 38.08%	19,788 $3.23 Million
Q1 2022 May 16, 2022	SELL	$127.18 - $173.91 $1.55 Million - $2.12 Million	-12,171 Reduced 38.08%	19,788 $3.23 Million
Q4 2021 Sep 21, 2023	BUY	$159.56 - $209.29 $2.95 Million - $3.88 Million	18,515 Added 137.72%	31,959 $5.42 Million
Q4 2021 Feb 14, 2022	BUY	$159.56 - $209.29 $2.95 Million - $3.88 Million	18,515 Added 137.72%	31,959 $5.42 Million
Q3 2021 Sep 21, 2023	SELL	$169.75 - $207.73 $525,546 - $643,132	-3,096 Reduced 18.72%	13,444 $2.54 Million
Q3 2021 Nov 15, 2021	SELL	$169.75 - $207.73 $525,546 - $643,132	-3,096 Reduced 18.72%	13,444 $2.54 Million
Q2 2021 Sep 21, 2023	SELL	$128.63 - $176.89 $278,355 - $382,789	-2,164 Reduced 11.57%	16,540 $2.8 Million
Q2 2021 Aug 16, 2021	SELL	$128.63 - $176.89 $278,355 - $382,789	-2,164 Reduced 11.57%	16,540 $2.8 Million
Q4 2020 Sep 21, 2023	SELL	$122.97 - $147.0 $3.45 Million - $4.12 Million	-28,022 Reduced 59.97%	18,704 $2.43 Million
Q4 2020 Feb 16, 2021	BUY	$122.97 - $147.0 $637,722 - $762,342	5,186 Added 38.36%	18,704 $2.43 Million
Q3 2020 Nov 13, 2020	SELL	$121.19 - $165.49 $3,150 - $4,302	-26 Reduced 0.19%	13,518 $1.97 Million
Q2 2020 Aug 14, 2020	SELL	$104.21 - $156.44 $360,566 - $541,282	-3,460 Reduced 20.35%	13,544 $2.01 Million
Q1 2020 May 15, 2020	BUY	$93.12 - $133.99 $482,734 - $694,604	5,184 Added 43.86%	17,004 $1.85 Million
Q4 2019 Feb 13, 2020	BUY	$74.51 - $124.23 $641,307 - $1.07 Million	8,607 Added 267.88%	11,820 $1.36 Million
Q3 2019 Nov 13, 2019	BUY	$70.9 - $87.82 $227,801 - $282,165	3,213 New	3,213 $258,000
Q4 2018 Feb 14, 2019	SELL	$62.67 - $88.33 $1.95 Million - $2.75 Million	-31,102 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$87.52 - $122.67 $2.69 Million - $3.77 Million	30,702 Added 7675.5%	31,102 $2.72 Million
Q2 2018 Aug 14, 2018	SELL	$88.31 - $107.8 $2.3 Million - $2.8 Million	-25,995 Reduced 98.48%	400 $39,000
Q1 2018 May 15, 2018	BUY	$115.92 - $148.54 $1.38 Million - $1.77 Million	11,895 Added 82.03%	26,395 $3.14 Million
Q4 2017 Feb 14, 2018	BUY	$114.49 - $139.98 $228,980 - $279,960	2,000 Added 16.0%	14,500 $1.84 Million
Q3 2017 Nov 14, 2017	BUY	$72.53 - $118.27 $906,625 - $1.48 Million	12,500	12,500 $1.47 Million

Others Institutions Holding ALNY

# of Institutions

641

Shares Held

109M

Call Options Held

1.28M

Put Options Held

1.21M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $29B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Account

Jefferies Group LLC Alnylam Pharmaceuticals, Inc. Transaction History